Whitehawk Therapeutics, Inc. (WHWK)

Whitehawk Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	144.94	28.67	62.89	39.02	148.99	4.46
Short-Term Investments	32.26	18.57	45.96	133.54	-	-
Cash & Short-Term Investments	177.2	47.24	108.85	172.56	148.99	4.46
Cash Growth	125.54%	-56.60%	-36.92%	15.82%	3244.31%	-72.09%
Receivables	-	5.9	5.49	1.86	-	14.15
Inventory	-	5.31	6.43	1.86	-	-
Prepaid Expenses	1.47	2.84	3.83	3.75	2.28	0.08
Total Current Assets	178.67	61.29	124.59	180.03	151.27	18.69
Property, Plant & Equipment	0.01	7.63	5.97	2.03	0.61	0.14
Other Intangible Assets	-	-	-	-	3.81	-
Other Long-Term Assets	2.14	1.4	1.87	2.18	2.21	-
Total Assets	180.82	70.32	132.42	184.24	157.91	18.83
Accounts Payable	3.34	2.16	5.9	3.52	6.44	2.39
Accrued Expenses	5.42	14.65	14.31	13.35	8.7	6.9
Current Portion of Long-Term Debt	-	-	-	-	-	9.03
Current Portion of Leases	-	0.27	0.43	0.39	0.13	0.13
Other Current Liabilities	-	-	5.76	1.57	-	11.61
Total Current Liabilities	8.76	17.07	26.4	18.84	15.27	30.06
Long-Term Debt	-	-	-	-	-	1.1
Long-Term Leases	-	0.57	0.83	1.27	0.47	-
Other Long-Term Liabilities	-	0.2	-	5.76	5.76	0.1
Total Liabilities	8.76	17.84	27.23	25.86	21.5	31.26
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	484.31	385.11	374.13	361.69	279.09	20.16
Retained Earnings	-312.25	-332.65	-268.96	-203.2	-142.69	-32.6
Comprehensive Income & Other	0.01	0.02	0.03	-0.12	-	-
Total Common Equity	172.07	52.48	105.2	158.38	136.41	-12.43
Shareholders' Equity	172.07	52.48	105.2	158.38	136.41	-12.43
Total Liabilities & Equity	180.82	70.32	132.42	184.24	157.91	18.83
Total Debt	-	0.83	1.27	1.66	0.61	10.26
Net Cash (Debt)	177.2	46.4	107.58	170.9	148.38	-5.8
Net Cash Growth	128.61%	-56.87%	-37.05%	15.17%	-	-
Net Cash Per Share	4.35	1.72	4.00	7.59	16.63	-2.28
Filing Date Shares Outstanding	47.13	46.78	24.55	24.44	20.93	8.02
Total Common Shares Outstanding	47.13	24.68	24.55	24.44	20.89	8.02
Working Capital	169.92	44.21	98.19	161.19	136	-11.37
Book Value Per Share	3.65	2.13	4.28	6.48	6.53	-1.55
Tangible Book Value	172.07	52.48	105.2	158.38	132.6	-12.43
Tangible Book Value Per Share	3.65	2.13	4.28	6.48	6.35	-1.55
Machinery	0.38	0.59	0.55	0.4	0.09	-
Construction In Progress	-	6.59	4.39	0.08	-	-
Leasehold Improvements	-	0.13	0.13	0.13	-	-

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q